Article
New target-HMGCR inhibitors for the treatment of primary sclerosing cholangitis: a drug Mendelian randomization study
2024-04-25
Abstract excerpt
<title>Abstract</title> <p>Primary sclerosing cholangitis (PSC) lacks specific drugs. Statins, inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR), have shown potential for improving PSC prognosis, but their therapeutic efficacy remains controversial. We analyzed HMGCR single nucleotide polymorphisms (SNPs) from published genome-wide association studies using Mendelian randomization (MR) to asse...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5b2bfa33-e41b-52db-9ddd-da46ed5b660a
- DOI
- 10.21203/rs.3.rs-4262308/v1
